131 related articles for article (PubMed ID: 37858540)
21. Stabilizing Antibody Cocktails for Mass Cytometry.
Schulz AR; Baumgart S; Schulze J; Urbicht M; Grützkau A; Mei HE
Cytometry A; 2019 Aug; 95(8):910-916. PubMed ID: 31058420
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric analysis of apoptosis by flow cytometry.
Telford WG; Komoriya A; Packard BZ; Bagwell CB
Methods Mol Biol; 2011; 699():203-27. PubMed ID: 21116985
[TBL] [Abstract][Full Text] [Related]
23. Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth.
Gaudillière B; Ganio EA; Tingle M; Lancero HL; Fragiadakis GK; Baca QJ; Aghaeepour N; Wong RJ; Quaintance C; El-Sayed YY; Shaw GM; Lewis DB; Stevenson DK; Nolan GP; Angst MS
Cytometry A; 2015 Sep; 87(9):817-29. PubMed ID: 26190063
[TBL] [Abstract][Full Text] [Related]
24. Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples.
Krutzik PO; Trejo A; Schulz KR; Nolan GP
Methods Mol Biol; 2011; 699():179-202. PubMed ID: 21116984
[TBL] [Abstract][Full Text] [Related]
25. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.
Rawstron AC; Orfao A; Beksac M; Bezdickova L; Brooimans RA; Bumbea H; Dalva K; Fuhler G; Gratama J; Hose D; Kovarova L; Lioznov M; Mateo G; Morilla R; Mylin AK; Omedé P; Pellat-Deceunynck C; Perez Andres M; Petrucci M; Ruggeri M; Rymkiewicz G; Schmitz A; Schreder M; Seynaeve C; Spacek M; de Tute RM; Van Valckenborgh E; Weston-Bell N; Owen RG; San Miguel JF; Sonneveld P; Johnsen HE;
Haematologica; 2008 Mar; 93(3):431-8. PubMed ID: 18268286
[TBL] [Abstract][Full Text] [Related]
26. Impact of recent innovations in the use of mass cytometry in support of drug development.
Nassar AF; Ogura H; Wisnewski AV
Drug Discov Today; 2015 Oct; 20(10):1169-75. PubMed ID: 26092491
[TBL] [Abstract][Full Text] [Related]
27. Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry.
Schulz AR; Mei HE
Methods Mol Biol; 2019; 1989():93-108. PubMed ID: 31077101
[TBL] [Abstract][Full Text] [Related]
28. A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer.
Lee BH; Kelly G; Bradford S; Davila M; Guo XV; Amir ED; Thrash EM; Solga MD; Lannigan J; Sellers B; Candia J; Tsang J; Montgomery RR; Tamaki SJ; Sigdel TK; Sarwal MM; Lanier LL; Tian Y; Kim C; Hinz D; Peters B; Sette A; Rahman AH
Cytometry A; 2019 Sep; 95(9):1019-1030. PubMed ID: 31364278
[TBL] [Abstract][Full Text] [Related]
29. Live Cell Barcoding for Efficient Analysis of Small Samples by Mass Cytometry.
Wagar LE
Methods Mol Biol; 2019; 1989():125-135. PubMed ID: 31077103
[TBL] [Abstract][Full Text] [Related]
30. Barcoding of live peripheral blood mononuclear cells to assess immune cell phenotypes using full spectrum flow cytometry.
Junker F; Camillo Teixeira P
Cytometry A; 2022 Nov; 101(11):909-921. PubMed ID: 35150047
[TBL] [Abstract][Full Text] [Related]
31. Quantification of intracellular proteins and monitoring therapy using flow cytometry.
Chang RL; Yeh CH; Albitar M
Curr Drug Targets; 2010 Aug; 11(8):994-9. PubMed ID: 20426764
[TBL] [Abstract][Full Text] [Related]
32. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum.
Bendall SC; Simonds EF; Qiu P; Amir el-AD; Krutzik PO; Finck R; Bruggner RV; Melamed R; Trejo A; Ornatsky OI; Balderas RS; Plevritis SK; Sachs K; Pe'er D; Tanner SD; Nolan GP
Science; 2011 May; 332(6030):687-96. PubMed ID: 21551058
[TBL] [Abstract][Full Text] [Related]
33. Acquisition, Processing, and Quality Control of Mass Cytometry Data.
Lee BH; Rahman AH
Methods Mol Biol; 2019; 1989():13-31. PubMed ID: 31077096
[TBL] [Abstract][Full Text] [Related]
34. Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF).
Smets T; Stevenaert F; Adams HC; Vanhoof G
Methods Mol Biol; 2018; 1792():47-54. PubMed ID: 29797251
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous Detection of Protein and mRNA in Jurkat and KG-1a Cells by Mass Cytometry.
Mavropoulos A; Allo B; He M; Park E; Majonis D; Ornatsky O
Cytometry A; 2017 Dec; 91(12):1200-1208. PubMed ID: 29194963
[TBL] [Abstract][Full Text] [Related]
36. Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis.
Frassanito MA; Cusmai A; Iodice G; Dammacco F
Blood; 2001 Jan; 97(2):483-9. PubMed ID: 11154226
[TBL] [Abstract][Full Text] [Related]
37. A novel aryl-guanidinium derivative, VP79s, targets the signal transducer and activator of transcription 3 signaling pathway, downregulates myeloid cell leukaemia-1 and exhibits preclinical activity against multiple myeloma.
Amet R; Previtali V; Mihigo HB; Sheridan E; Brophy S; Hante NK; Santos-Martinez MJ; Hayden PJ; Browne PV; Rozas I; McElligott AM; Zisterer DM
Life Sci; 2022 Feb; 290():120236. PubMed ID: 34953891
[TBL] [Abstract][Full Text] [Related]
38. High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery.
Zielinski JM; Luke JJ; Guglietta S; Krieg C
Front Immunol; 2021; 12():590742. PubMed ID: 33868223
[TBL] [Abstract][Full Text] [Related]
39. Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
Wistuba-Hamprecht K; Martens A; Weide B; Teng KW; Zelba H; Guffart E; Chen J; Garbe C; Newell EW; Larbi A; Pawelec G
J Immunol; 2017 Jan; 198(2):927-936. PubMed ID: 27986910
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads.
Bringeland GH; Bader L; Blaser N; Budzinski L; Schulz AR; Mei HE; Myhr KM; Vedeler CA; Gavasso S
Cytometry A; 2019 Mar; 95(3):314-322. PubMed ID: 30688025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
